litlas
Log inCreate account

Christopher G. Sobey

Active 1996–2025

105
Papers
20,233
Citations
77
h-index
103
i10-index

Citations

Citations per year for Christopher G. Sobey1977: 1 citations1992: 1 citations1996: 1 citations1997: 13 citations1998: 23 citations1999: 35 citations2000: 35 citations2001: 30 citations2002: 42 citations2003: 38 citations2004: 31 citations2005: 33 citations2006: 29 citations2007: 25 citations2008: 48 citations2009: 56 citations2010: 62 citations2011: 94 citations2012: 137 citations2013: 140 citations2014: 129 citations2015: 162 citations2016: 190 citations2017: 194 citations2018: 227 citations2019: 841 citations2020: 1,110 citations2021: 1,327 citations2022: 961 citations2023: 701 citations2024: 1,187 citations2025: 556 citations2026: 6 citations1978–1991: no citations, so these years are not shown1993–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 2,115 citing papers, 22.2% of this breakdownUnited States: 1,848 citing papers, 19.4% of this breakdownUnited Kingdom: 510 citing papers, 5.4% of this breakdownAustralia: 480 citing papers, 5% of this breakdownGermany: 448 citing papers, 4.7% of this breakdownItaly: 401 citing papers, 4.2% of this breakdownCanada: 281 citing papers, 3% of this breakdownSpain: 244 citing papers, 2.6% of this breakdownJapan: 223 citing papers, 2.3% of this breakdownIndia: 203 citing papers, 2.1% of this breakdownFrance: 201 citing papers, 2.1% of this breakdownSouth Korea: 197 citing papers, 2.1% of this breakdown
0%22.2%Other 24.9%

Institutions

Fields

  • Medicine43.3%
  • Biochemistry, Genetics and Molecular Biology25.5%
  • Neuroscience16.3%
  • Immunology and Microbiology6.7%
  • Nursing2.6%
  • Environmental Science1.8%
  • Other3.8%

Topics

  • Neuroinflammation and Neurodegeneration Mechanisms5.7%
  • Inflammasome and immune disorders3.1%
  • Nitric Oxide and Endothelin Effects2.5%
  • Neurological Disease Mechanisms and Treatments2.3%
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms2%
  • Immune cells in cancer1.3%
  • Other83.1%

Coauthors

All papers

Open in search
  1. ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020

    Authors: Elliot Lilley, S. Clare Stanford, David Kendall, S P H Alexander, Giuseppe Cirino, James R. Docherty, Christopher H. George, Paul A. Insel, Angelo A. Izzo, Yong Ji, Reynold A. Panettieri, Christopher G. Sobey, Barbara Stefañska, Gary J. Stephens, Mauro Martins Teixeira, Amrita Ahluwalia - British Journal of Pharmacology 2020 cited by 1,134

  2. Planning experiments: Updated guidance on experimental design and analysis and their reporting III

    Authors: Michael J. Curtis, S P H Alexander, Giuseppe Cirino, Christopher H. George, David A. Kendall, Paul A. Insel, Angelo A. Izzo, Yong Ji, Reynold A. Panettieri, Hemal H. Patel, Christopher G. Sobey, S. Clare Stanford, Phil Stanley, Barbara Stefañska, Gary J. Stephens, Mauro Martins Teixeira, Nathalie Vergnolle, Amrita Ahluwalia - British Journal of Pharmacology 2022 cited by 510

  3. Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology

    Authors: Steve P H Alexander, Richard Roberts, Brad R. S. Broughton, Christopher G. Sobey, Christopher H George, S. Clare Stanford, Giuseppe Cirino, James R. Docherty, Mark A. Giembycz, Daniël Hoyer, Paul A. Insel, Angelo A. Izzo, Yong Ji, David J. MacEwan, Jonathan E. Mangum, Sue Wonnacott, Amrita Ahluwalia - British Journal of Pharmacology 2018 cited by 855

  4. Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment

    Authors: Vismitha Rajeev, David Y. Fann, Quynh Nhu Dinh, Hyun Ah Kim, T. Michael De Silva, Mitchell K.P. Lai, Christopher Chen, Grant R. Drummond, Christopher G. Sobey, Thiruma V. Arumugam - Theranostics 2022 cited by 274

  5. The Concise Guide to PHARMACOLOGY 2023/24: Introduction and Other Protein Targets

    Authors: S P H Alexander, Eamonn Kelly, Alistair Mathie, John A. Peters, Emma L. Veale, Jane F Armstrong, O. Buneman, Elena Faccenda, Simon D Harding, Michael Spedding, John A. Cidlowski, Doriano Fabbro, Anthony P. Davenport, Jörg Striessnig, Jamie A. Davies, Katelin E. Ahlers‐Dannen, Mohammed Alqinyah, Thiruma V. Arumugam, Christopher Bodle, Josephine Buo Dagner, Bandana Chakravarti, Shreoshi Pal Choudhuri, Kirk M. Druey, Rory A. Fisher, Kyle J. Gerber, John R. Hepler, Shelley B. Hooks, Havish S. Kantheti, Behirda Karaj, Somayeh Layeghi‐Ghalehsoukhteh, Jae‐Kyung Lee, Zili Luo, Kirill A. Martemyanov, Luke D. Mascarenhas, Harrison J. McNabb, Carolina Montañez‐Miranda, Osita W. Ogujiofor, H. T. Phan, David L. Roman, Vincent Shaw, Benita Sjögren, Christopher G. Sobey, Mackenzie M. Spicer, Katherine E. Squires, Laurie P. Sutton, Menbere Wendimu, Thomas M. Wilkie, Keqiang Xie, Qian Zhang, Yalda Zolghadri - British Journal of Pharmacology 2023 cited by 213

  6. Chronic cerebral hypoperfusion: a critical feature in unravelling the etiology of vascular cognitive impairment

    Authors: Vismitha Rajeev, Yuek Ling Chai, Luting Poh, Sharmelee Selvaraji, David Y. Fann, Dong‐Gyu Jo, T. Michael De Silva, Grant R. Drummond, Christopher G. Sobey, Thiruma V. Arumugam, Christopher Chen, Mitchell K.P. Lai - Acta Neuropathologica Communications 2023 cited by 192

  7. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension

    Authors: Shalini M Krishnan, Yeong Hann Ling, Brooke M. Huuskes, Dorota Ferens, Narbada Saini, Christopher T. Chan, Henry Diep, Michelle M. Kett, Chrishan S. Samuel, Barbara K. Kemp‐Harper, Avril A. B. Robertson, Matthew A. Cooper, Karlheinz Peter, Eicke Latz, Ashley Mansell, Christopher G. Sobey, Grant R. Drummond, Antony Vinh - Cardiovascular Research 2018 cited by 269

  8. Apoptotic Mechanisms After Cerebral Ischemia

    Authors: Brad R. S. Broughton, David C. Reutens, Christopher G. Sobey - Stroke 2009 cited by 1,250

  9. Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers

    Authors: Michael J. Curtis, Steve Alexander, Giuseppe Cirino, James R. Docherty, Christopher H George, Mark A. Giembycz, Daniël Hoyer, Paul A. Insel, Angelo A. Izzo, Yong Ji, David J. MacEwan, Christopher G. Sobey, S. Clare Stanford, Mauro Martins Teixeira, Sue Wonnacott, Amrita Ahluwalia - British Journal of Pharmacology 2018 cited by 1,359

  10. Immune mechanisms of hypertension

    Authors: Grant R. Drummond, Antony Vinh, Tomasz J. Guzik, Christopher G. Sobey - Nature reviews. Immunology 2019 cited by 437

  11. The role of inflammasomes in vascular cognitive impairment

    Authors: Luting Poh, Wei Liang Sim, Dong‐Gyu Jo, Quynh Nhu Dinh, Grant R. Drummond, Christopher G. Sobey, Christopher Chen, Mitchell K.P. Lai, David Y. Fann, Thiruma V. Arumugam - Molecular Neurodegeneration 2022 cited by 172

  12. Evidence that NF-κB and MAPK Signaling Promotes NLRP Inflammasome Activation in Neurons Following Ischemic Stroke

    Authors: David Y. Fann, Yun‐An Lim, Yi-Lin Cheng, Ker-Zhing Lok, Prasad Chunduri, Sang-Ha Baik, Grant R. Drummond, S. Thameem Dheen, Christopher G. Sobey, Dong‐Gyu Jo, Christopher Chen, Thiruma V. Arumugam - Molecular Neurobiology 2017 cited by 320

  13. Bacteriophages in Natural and Artificial Environments

    Authors: Steven Batinovic, Flavia Wassef, Sarah A. Knowler, Daniel Rice, Cassandra R. Stanton, J. Rose, Joseph Tucci, Tadashi Nittami, Antony Vinh, Grant R. Drummond, Christopher G. Sobey, Hiu Tat Chan, Robert J. Seviour, Steve Petrovski, Ashley E. Franks - Pathogens 2019 cited by 253

  14. Pathophysiology, treatment, and animal and cellular models of human ischemic stroke

    Authors: Trent M. Woodruff, John Thundyil, Sung‐Chun Tang, Christopher G. Sobey, Stephen M. Taylor, Thiruma V. Arumugam - Molecular Neurodegeneration 2011 cited by 597

  15. Pathogenesis of acute stroke and the role of inflammasomes

    Authors: David Y. Fann, Seung-Yoon Lee, Silvia Manzanero, Prasad Chunduri, Christopher G. Sobey, Thiruma V. Arumugam - Ageing Research Reviews 2013 cited by 345

  16. Roles of Inflammation, Oxidative Stress, and Vascular Dysfunction in Hypertension

    Authors: Quynh Nhu Dinh, Grant R. Drummond, Christopher G. Sobey, Sophocles Chrissobolis - BioMed Research International 2014 cited by 598

  17. Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke

    Authors: David Y. Fann, S-Y Lee, Silvia Manzanero, S-C Tang, Mathias Gelderblom, Prasad Chunduri, Christian Bernreuther, Markus Glatzel, Y-L Cheng, John Thundyil, Alexander Widiapradja, K-Z Lok, Sok Lin Foo, YC Wang, Yu‐I Li, Grant R. Drummond, Milan Bašta, Tim Magnus, Dong‐Gyu Jo, Mark P. Mattson, Christopher G. Sobey, Thiruma V. Arumugam - Cell Death and Disease 2013 cited by 490

  18. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets

    Authors: Grant R. Drummond, Stavros Selemidis, Kathy K. Griendling, Christopher G. Sobey - Nature Reviews Drug Discovery 2011 cited by 885

  19. Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt‐induced hypertension in mice

    Authors: Shalini M Krishnan, Jennifer K. Dowling, Yeong Hann Ling, Henry Diep, Christopher T. Chan, Dorota Ferens, M. M. Kett, Anita A. Pinar, Chrishan S. Samuel, Antony Vinh, Thiruma V. Arumugam, Tim D. Hewitson, B. Kemp-Harper, Avril A. B. Robertson, Matthew A. Cooper, Eicke Latz, Ashley Mansell, Christopher G. Sobey, Grant R. Drummond - British Journal of Pharmacology 2015 cited by 187

  20. Endothelial NADPH oxidases: which NOX to target in vascular disease?

    Authors: Grant R. Drummond, Christopher G. Sobey - Trends in Endocrinology and Metabolism 2014 cited by 310

  21. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein Targets

    Authors: S P H Alexander, Eamonn Kelly, Alistair Mathie, John A. Peters, Emma L. Veale, Jane F Armstrong, Elena Faccenda, Simon D Harding, Adam J Pawson, Christopher Southan, O. Buneman, John A. Cidlowski, Arthur Christopoulos, Anthony P. Davenport, Doriano Fabbro, Michael Spedding, Jörg Striessnig, Jamie A. Davies, Katelin E. Ahlers‐Dannen, Mohammed Alqinyah, Thiruma V. Arumugam, Christopher Bodle, Josephine Buo Dagner, Bandana Chakravarti, Shreoshi Pal Choudhuri, Kirk M. Druey, Rory A. Fisher, Kyle J. Gerber, John R. Hepler, Shelley B. Hooks, Havish S. Kantheti, Behirda Karaj, Somayeh Layeghi‐Ghalehsoukhteh, Jae‐Kyung Lee, Zili Luo, Kirill A. Martemyanov, Luke D. Mascarenhas, Harrison J. McNabb, Carolina Montañez‐Miranda, Osita W. Ogujiofor, H. T. Phan, David L. Roman, Vincent Shaw, Benita Sjögren, Christopher G. Sobey, Mackenzie M. Spicer, Katherine E. Squires, Laurie P. Sutton, Menbere Wendimu, Thomas M. Wilkie, Keqiang Xie, Qian Zhang, Yalda Zolghadri - British Journal of Pharmacology 2021 cited by 275

  22. Adiponectin receptor signalling in the brain

    Authors: John Thundyil, Dale Pavlovski, Christopher G. Sobey, Thiruma V. Arumugam - British Journal of Pharmacology 2011 cited by 278

  23. Evidence that NLRC4 inflammasome mediates apoptotic and pyroptotic microglial death following ischemic stroke

    Authors: Luting Poh, Sung-Wook Kang, Sang‐Ha Baik, Gavin Ng, David T. She, Priyanka Balaganapathy, S. Thameem Dheen, Tim Magnus, Mathias Gelderblom, Christopher G. Sobey, Edward H. Koo, David Y. Fann, Thiruma V. Arumugam - Brain Behavior and Immunity 2018 cited by 199

  24. IL‐1β and IL‐18: inflammatory markers or mediators of hypertension?

    Authors: Shalini M Krishnan, Christopher G. Sobey, Eicke Latz, Ashley Mansell, Grant R. Drummond - British Journal of Pharmacology 2014 cited by 212